Avidity Biosciences (RNA) P/E Ratio
P/E Ratio as of Jul 2, 2025: -9.77
Average-10.39
Median-9.95
Minimum-12.06
Maximum-9.45
-9.77
Past Month+0.54 (5.24%)
The P/E ratio for Avidity Biosciences (RNA) is -9.77 as of Jul 2, 2025. This represents a decrease of -20.11% compared to its 12-month average P/E ratio of -12.23. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Avidity Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Avidity Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Avidity Biosciences to industry peers.
Avidity Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Avidity Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Avidity Biosciences to industry peers.
Avidity Biosciences (RNA) P/E Ratio Insights
See Avidity Biosciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Avidity Biosciences (RNA)
Order type
Buy in
Order amount
Est. shares
0 shares
Avidity Biosciences (RNA) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $28.46 | -9.47 |
| Jun 2, 2025 | $33.17 | -11.04 |
| May 1, 2025 | $32.69 | -11.28 |
| Apr 1, 2025 | $26.74 | -9.22 |
| Mar 3, 2025 | $29.22 | -10.08 |
| Feb 3, 2025 | $31.96 | -11.03 |
| Jan 2, 2025 | $31.18 | -10.76 |
Avidity Biosciences (RNA) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -9.77 | -2.59% |
| 2024 | -10.03 | +231.02% |
| 2023 | -3.03 | -55.44% |
| 2022 | -6.80 | -19.05% |
| 2021 | -8.40 | -61.04% |
| 2020 | -21.56 | — |
FAQs About Avidity Biosciences (RNA) P/E ratio
The latest P/E ratio of Avidity Biosciences (RNA) is -9.77, as of Jul 2, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Avidity Biosciences’s last 12-month average P/E ratio is -12.23, compared to its current P/E ratio of -9.77. This reflects a decrease of -20.11%.
Avidity Biosciences’s current P/E ratio of -9.77 is lower than its last 12-month average P/E of -12.23. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Avidity Biosciences’s average P/E ratio over the last 3 years is -7.61. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Avidity Biosciences’s average P/E ratio over the last 5 years is -8.32. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.